Product
CIN-103
1 clinical trial
1 indication
Indication
Irritable Bowel Syndrome with DiarrheaClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Status: Recruiting, Estimated PCD: 2025-02-09